<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Fibrinolytic | Hematology</title>
<meta name="author" content="Brett M. Rice">
<meta name="description" content="Overview of the Fibrinolytic System  Definition: The fibrinolytic system is responsible for the breakdown and removal of fibrin clots from blood vessels once tissue repair has occurred Purpose: To...">
<meta name="generator" content="bookdown 0.42 with bs4_book()">
<meta property="og:title" content="Fibrinolytic | Hematology">
<meta property="og:type" content="book">
<meta property="og:description" content="Overview of the Fibrinolytic System  Definition: The fibrinolytic system is responsible for the breakdown and removal of fibrin clots from blood vessels once tissue repair has occurred Purpose: To...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Fibrinolytic | Hematology">
<meta name="twitter:description" content="Overview of the Fibrinolytic System  Definition: The fibrinolytic system is responsible for the breakdown and removal of fibrin clots from blood vessels once tissue repair has occurred Purpose: To...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><script src="libs/bs3compat-0.9.0/transition.js"></script><script src="libs/bs3compat-0.9.0/tabs.js"></script><script src="libs/bs3compat-0.9.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><meta name="google-adsense-account" content="ca-pub-1344282930858290">
<script async src="https://www.googletagmanager.com/gtag/js?id=G-JERRQQFPF4"></script><script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());

      gtag('config', 'G-JERRQQFPF4');
    </script><script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="style.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Hematology</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2>Table of contents</h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">About</a></li>
<li><a class="" href="content-areas.html">Content Areas</a></li>
<li><a class="" href="author.html">Author</a></li>
<li><a class="" href="ascp-boc.html">ASCP BOC</a></li>
<li><a class="" href="reading-list.html">Reading List</a></li>
<li class="book-part">Erythrocytes</li>
<li><a class="" href="rbc-production.html">RBC Production</a></li>
<li><a class="" href="rbc-function.html">RBC Function</a></li>
<li><a class="" href="rbc-destruction.html">RBC Destruction</a></li>
<li><a class="" href="anemais.html">Anemais</a></li>
<li><a class="" href="microcytic.html">Microcytic</a></li>
<li><a class="" href="iron-deficiency.html">Iron Deficiency</a></li>
<li><a class="" href="chronic-disease.html">Chronic Disease</a></li>
<li><a class="" href="thalassemias.html">Thalassemias</a></li>
<li><a class="" href="sideroblastic.html">Sideroblastic</a></li>
<li><a class="" href="porphyria.html">Porphyria</a></li>
<li><a class="" href="normocytic.html">Normocytic</a></li>
<li><a class="" href="hereditary-hemolytic.html">Hereditary Hemolytic</a></li>
<li><a class="" href="acquired-hemolytic.html">Acquired Hemolytic</a></li>
<li><a class="" href="hypoproliferative.html">Hypoproliferative</a></li>
<li><a class="" href="acute-hemorrhage.html">Acute Hemorrhage</a></li>
<li><a class="" href="macrocytic.html">Macrocytic</a></li>
<li><a class="" href="megaloblastic.html">Megaloblastic</a></li>
<li><a class="" href="nonmegaloblastic.html">Nonmegaloblastic</a></li>
<li><a class="" href="hemoglobinopathies.html">Hemoglobinopathies</a></li>
<li><a class="" href="erythrocytosis.html">Erythrocytosis</a></li>
<li class="book-part">Leukocytes</li>
<li><a class="" href="wbc-production.html">WBC Production</a></li>
<li><a class="" href="wbc-function.html">WBC Function</a></li>
<li><a class="" href="wbc-destruction.html">WBC Destruction</a></li>
<li><a class="" href="benign-disorders.html">Benign Disorders</a></li>
<li><a class="" href="myeloid.html">Myeloid</a></li>
<li><a class="" href="lymphoid.html">Lymphoid</a></li>
<li><a class="" href="myeloid-neoplasia.html">Myeloid Neoplasia</a></li>
<li><a class="" href="aml.html">AML</a></li>
<li><a class="" href="myelodysplastic.html">Myelodysplastic</a></li>
<li><a class="" href="myeloproliferative.html">Myeloproliferative</a></li>
<li><a class="" href="lymphoid-neoplasia.html">Lymphoid Neoplasia</a></li>
<li><a class="" href="acute-lymphoid.html">Acute Lymphoid</a></li>
<li><a class="" href="chronic-b-cell.html">Chronic B-Cell</a></li>
<li><a class="" href="chronic-t-cell.html">Chronic T-Cell</a></li>
<li><a class="" href="plasma-cell.html">Plasma Cell</a></li>
<li><a class="" href="hereditary.html">Hereditary</a></li>
<li class="book-part">Platelets</li>
<li><a class="" href="plt-production.html">PLT Production</a></li>
<li><a class="" href="plt-function.html">PLT Function</a></li>
<li><a class="" href="plt-destruction.html">PLT Destruction</a></li>
<li><a class="" href="quantitative.html">Quantitative</a></li>
<li><a class="" href="thrombocytopenia-1.html">Thrombocytopenia</a></li>
<li><a class="" href="destruction.html">Destruction</a></li>
<li><a class="" href="production.html">Production</a></li>
<li><a class="" href="pseudo.html">Pseudo</a></li>
<li><a class="" href="thrombocytosis.html">Thrombocytosis</a></li>
<li><a class="" href="qualitative.html">Qualitative</a></li>
<li><a class="" href="von-willebrand.html">von Willebrand</a></li>
<li><a class="" href="bernard-soulier.html">Bernard-Soulier</a></li>
<li><a class="" href="glanzmann.html">Glanzmann</a></li>
<li class="book-part">Laboratory</li>
<li><a class="" href="cell-counts.html">Cell Counts</a></li>
<li><a class="" href="manual.html">Manual</a></li>
<li><a class="" href="automated.html">Automated</a></li>
<li><a class="" href="retics.html">Retics</a></li>
<li><a class="" href="differentials.html">Differentials</a></li>
<li><a class="" href="morphologies.html">Morphologies</a></li>
<li><a class="" href="hemoglobin.html">Hemoglobin</a></li>
<li><a class="" href="quantitative-1.html">Quantitative</a></li>
<li><a class="" href="qualitative-1.html">Qualitative</a></li>
<li><a class="" href="electrophoresis.html">Electrophoresis</a></li>
<li><a class="" href="hplc.html">HPLC</a></li>
<li><a class="" href="sickle-solubility.html">Sickle Solubility</a></li>
<li><a class="" href="hematocrit.html">Hematocrit</a></li>
<li><a class="" href="indices.html">Indices</a></li>
<li><a class="" href="hemolysis.html">Hemolysis</a></li>
<li><a class="" href="special-stains.html">Special Stains</a></li>
<li><a class="" href="other-studies.html">Other Studies</a></li>
<li><a class="" href="esr.html">ESR</a></li>
<li><a class="" href="g6pd.html">G6PD</a></li>
<li><a class="" href="heinz-body.html">Heinz Body</a></li>
<li><a class="" href="flow-cytometry.html">Flow Cytometry</a></li>
<li><a class="" href="leukemia.html">Leukemia</a></li>
<li><a class="" href="lymphoma.html">Lymphoma</a></li>
<li><a class="" href="lymphocyte-subsets.html">Lymphocyte Subsets</a></li>
<li><a class="" href="pnh.html">PNH</a></li>
<li><a class="" href="molecularcytogenetic.html">Molecular/Cytogenetic</a></li>
<li><a class="" href="recurring-abnormalities.html">Recurring Abnormalities</a></li>
<li><a class="" href="bcrabl1.html">BCR/ABL1</a></li>
<li><a class="" href="jak2.html">JAK2</a></li>
<li class="book-part">Hemostasis</li>
<li><a class="" href="coagulation-pathways.html">Coagulation Pathways</a></li>
<li><a class="" href="fibrinolytic-pathways.html">Fibrinolytic Pathways</a></li>
<li><a class="" href="vascular-system.html">Vascular System</a></li>
<li><a class="" href="disorders.html">Disorders</a></li>
<li><a class="" href="factor-deficiencies.html">Factor Deficiencies</a></li>
<li><a class="" href="hereditary-1.html">Hereditary</a></li>
<li><a class="" href="acquired.html">Acquired</a></li>
<li><a class="" href="inhibitors.html">Inhibitors</a></li>
<li><a class="active" href="fibrinolytic.html">Fibrinolytic</a></li>
<li><a class="" href="thrombophilia.html">Thrombophilia</a></li>
<li><a class="" href="dic.html">DIC</a></li>
<li><a class="" href="laboratory.html">Laboratory</a></li>
<li><a class="" href="ptinr.html">PT/INR</a></li>
<li><a class="" href="aptt.html">APTT</a></li>
<li><a class="" href="fibrinogen.html">Fibrinogen</a></li>
<li><a class="" href="d-dimer.html">D-dimer</a></li>
<li><a class="" href="thrombin-time.html">Thrombin Time</a></li>
<li><a class="" href="mixing-studies-1.html">Mixing Studies</a></li>
<li><a class="" href="factor-assays.html">Factor Assays</a></li>
<li><a class="" href="inhibitor-assays.html">Inhibitor Assays</a></li>
<li><a class="" href="von-willebrand-assays.html">von Willebrand Assays</a></li>
<li><a class="" href="platelet-function.html">Platelet Function</a></li>
<li><a class="" href="platelet-aggregation.html">Platelet Aggregation</a></li>
<li><a class="" href="thromboelastography.html">Thromboelastography</a></li>
<li><a class="" href="hypercoagulability.html">Hypercoagulability</a></li>
<li><a class="" href="assays.html">Assays</a></li>
<li><a class="" href="antiphospholipids.html">Antiphospholipids</a></li>
<li><a class="" href="protein-c.html">Protein C</a></li>
<li><a class="" href="protein-s.html">Protein S</a></li>
<li><a class="" href="molecular.html">Molecular</a></li>
<li><a class="" href="fv-leiden.html">FV Leiden</a></li>
<li><a class="" href="pt-20210.html">PT 20210</a></li>
<li><a class="" href="anti-xa.html">Anti-Xa</a></li>
<li><a class="" href="thrombin-inhibitors.html">Thrombin Inhibitors</a></li>
<li><a class="" href="heparin-neutralization.html">Heparin Neutralization</a></li>
</ul>

        <div class="book-extra" style="display:none;">
          <p><a id="book-repo" href="https://github.com/brettmrice/Clinical-Microbiology/blob">View book source <i class="fab fa-github"></i></a></p>
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="fibrinolytic" class="section level1 unnumbered">
<h1>Fibrinolytic<a class="anchor" aria-label="anchor" href="#fibrinolytic"><i class="fas fa-link"></i></a>
</h1>
<div id="overview-of-the-fibrinolytic-system" class="section level2 unnumbered">
<h2>
<strong>Overview of the Fibrinolytic System</strong><a class="anchor" aria-label="anchor" href="#overview-of-the-fibrinolytic-system"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Definition:</strong> The fibrinolytic system is responsible for the breakdown and removal of fibrin clots from blood vessels once tissue repair has occurred</li>
<li>
<strong>Purpose:</strong> To restore normal blood flow, prevent excessive clot formation, and maintain vascular patency</li>
<li>
<strong>Key Components:</strong>
<ul>
<li>Plasminogen</li>
<li>Plasmin</li>
<li>Plasminogen Activators</li>
<li>Plasmin Inhibitors</li>
<li>Fibrin Degradation Products (FDPs)</li>
</ul>
</li>
<li>
<strong>Disorders:</strong> Can be caused by:
<ul>
<li>Deficiency or dysfunction of components of the fibrinolytic system</li>
<li>Excessive activation or inhibition of fibrinolysis</li>
</ul>
</li>
</ul>
</div>
<div id="disorders-of-the-fibrinolytic-system" class="section level2 unnumbered">
<h2>
<strong>Disorders of the Fibrinolytic System</strong><a class="anchor" aria-label="anchor" href="#disorders-of-the-fibrinolytic-system"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong>Excessive Fibrinolysis (Hyperfibrinolysis)</strong></p>
<ul>
<li>
<strong>General Features:</strong> Leads to increased breakdown of fibrin clots and a bleeding tendency</li>
<li>
<strong>Common Causes:</strong>
<ul>
<li>Disseminated Intravascular Coagulation (DIC):
<ul>
<li>A complex disorder characterized by widespread activation of coagulation and fibrinolysis</li>
<li>DIC can lead to excessive fibrinolysis due to the consumption of coagulation factors and the release of plasminogen activators</li>
</ul>
</li>
<li>Liver Disease:
<ul>
<li>Impaired synthesis of α2-antiplasmin (the main inhibitor of plasmin) can lead to unopposed plasmin activity</li>
</ul>
</li>
<li>Malignancy:
<ul>
<li>Certain cancers (e.g., acute promyelocytic leukemia) can release tissue plasminogen activator (tPA), leading to excessive fibrinolysis</li>
</ul>
</li>
<li>Streptokinase or tPA Therapy:
<ul>
<li>Overuse or inappropriate use of thrombolytic agents can lead to excessive fibrinolysis</li>
</ul>
</li>
</ul>
</li>
<li>
<strong>Clinical Features:</strong>
<ul>
<li>Bleeding: Oozing from IV sites, surgical wounds, and mucosal surfaces</li>
<li>Thrombosis: Can also occur due to the underlying cause (e.g., malignancy)</li>
</ul>
</li>
<li>
<strong>Laboratory Findings:</strong>
<ul>
<li>Prolonged PT and aPTT: Due to consumption of coagulation factors</li>
<li>Decreased Fibrinogen Level: Due to plasmin degradation</li>
<li>Elevated D-dimer: A specific marker for cross-linked fibrin degradation</li>
<li>Elevated FDPs: Other fibrin degradation products are also increased</li>
<li>Decreased α2-Antiplasmin Level: In some cases of severe fibrinolysis</li>
</ul>
</li>
<li>
<strong>Treatment:</strong>
<ul>
<li>Treat the Underlying Cause: Essential for resolving the hyperfibrinolytic state</li>
<li>Supportive Care: Transfusions (platelets, fresh frozen plasma, cryoprecipitate) to replace consumed coagulation factors and platelets</li>
<li>Antifibrinolytic Agents:
<ul>
<li>Aminocaproic acid or tranexamic acid: Inhibit plasminogen activation and reduce fibrinolysis</li>
<li>Used with caution, as they can promote thrombosis if the underlying cause is not addressed</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p><strong>Impaired Fibrinolysis (Hypofibrinolysis)</strong></p>
<ul>
<li>
<strong>General Features:</strong> Leads to decreased breakdown of fibrin clots and an increased risk of thrombosis</li>
<li>
<strong>Causes:</strong>
<ul>
<li>Deficiency of Plasminogen: Rare inherited disorder</li>
<li>Deficiency of tPA or uPA: Rare inherited disorder</li>
<li>Elevated Levels of PAI-1: More common; can be acquired or inherited
<ul>
<li>Acquired: Associated with obesity, metabolic syndrome, and certain inflammatory conditions</li>
<li>Inherited: Rare mutations in the PAI-1 gene</li>
</ul>
</li>
<li>Thrombophilia: Inherited or acquired conditions that increase the risk of thrombosis (e.g., factor V Leiden, prothrombin mutation)</li>
</ul>
</li>
<li>
<strong>Clinical Features:</strong>
<ul>
<li>Increased Risk of Thrombosis:
<ul>
<li>Deep vein thrombosis (DVT)</li>
<li>Pulmonary embolism (PE)</li>
<li>Arterial thrombosis (stroke, myocardial infarction)</li>
</ul>
</li>
<li>May be asymptomatic until a thrombotic event occurs</li>
</ul>
</li>
<li>
<strong>Laboratory Findings:</strong>
<ul>
<li>Routine coagulation tests (PT and aPTT): Usually normal</li>
<li>D-dimer: May be normal or slightly elevated</li>
<li>Plasminogen Activity Assay: Decreased in plasminogen deficiency</li>
<li>tPA and PAI-1 Assays: May show decreased tPA or increased PAI-1 levels</li>
<li>Thrombophilia Testing: To evaluate for other inherited or acquired thrombotic risk factors</li>
</ul>
</li>
<li>
<strong>Treatment:</strong>
<ul>
<li>Anticoagulation:
<ul>
<li>Warfarin (Coumadin)</li>
<li>Direct oral anticoagulants (DOACs): Dabigatran, rivaroxaban, apixaban, edoxaban</li>
</ul>
</li>
<li>Thrombolytic Therapy:
<ul>
<li>Tissue plasminogen activator (tPA) to dissolve acute thrombi</li>
</ul>
</li>
<li>Management of Underlying Risk Factors:
<ul>
<li>Lifestyle modifications (e.g., weight loss, exercise)</li>
<li>Control of underlying medical conditions (e.g., diabetes, hyperlipidemia)</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div id="laboratory-testing-for-disorders-of-fibrinolysis" class="section level2 unnumbered">
<h2>
<strong>Laboratory Testing for Disorders of Fibrinolysis</strong><a class="anchor" aria-label="anchor" href="#laboratory-testing-for-disorders-of-fibrinolysis"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<p><strong>D-dimer Assay:</strong></p>
<ul>
<li>Measures the level of D-dimer in the blood</li>
<li>A negative D-dimer result can be used to rule out VTE in low-risk patients</li>
</ul>
</li>
<li>
<p><strong>Fibrinogen Level:</strong></p>
<ul>
<li>Measures the amount of fibrinogen in the blood</li>
<li>Decreased in DIC and severe liver disease</li>
</ul>
</li>
<li>
<p><strong>tPA and PAI-1 Assays:</strong></p>
<ul>
<li>Measure the levels of tPA and PAI-1 in the blood</li>
<li>Used to evaluate fibrinolytic capacity</li>
</ul>
</li>
<li>
<p><strong>Plasminogen Activity Assay:</strong></p>
<ul>
<li>Measures the activity of plasminogen in the blood</li>
<li>Decreased in plasminogen deficiency</li>
</ul>
</li>
<li>
<p><strong>Euglobulin Lysis Time:</strong></p>
<ul>
<li>Global assessment of fibrinolytic activity</li>
<li>Prolonged lysis time indicates impaired fibrinolysis</li>
</ul>
</li>
</ul>
</div>
<div id="key-terms-82" class="section level2 unnumbered">
<h2>
<strong>Key Terms</strong><a class="anchor" aria-label="anchor" href="#key-terms-82"><i class="fas fa-link"></i></a>
</h2>
<ul>
<li>
<strong>Fibrinolysis:</strong> The breakdown of fibrin clots</li>
<li>
<strong>Plasminogen:</strong> Inactive precursor to plasmin</li>
<li>
<strong>Plasmin:</strong> Active enzyme that degrades fibrin</li>
<li>
<strong>tPA (Tissue Plasminogen Activator):</strong> Plasminogen activator released by endothelial cells</li>
<li>
<strong>uPA (Urokinase Plasminogen Activator):</strong> Plasminogen activator found in various tissues and body fluids</li>
<li>
<strong>α2-Antiplasmin (α2-AP):</strong> Primary inhibitor of plasmin</li>
<li>
<strong>PAI-1 (Plasminogen Activator Inhibitor-1):</strong> Inhibitor of tPA and uPA</li>
<li>
<strong>Fibrin Degradation Products (FDPs):</strong> Fragments produced when plasmin degrades fibrin</li>
<li>
<strong>D-dimer:</strong> A specific marker for cross-linked fibrin degradation</li>
<li>
<strong>Thrombosis:</strong> Formation of a blood clot inside a blood vessel</li>
<li>
<strong>Embolism:</strong> A blood clot that travels from one location to another</li>
<li>
<strong>Disseminated Intravascular Coagulation (DIC):</strong> A consumptive coagulopathy with widespread clotting and bleeding</li>
<li>
<strong>Thrombophilia:</strong> A tendency to develop blood clots due to inherited or acquired factors</li>
</ul>
</div>
</div>
<!-- Scoll to TOC element -->
<script defer>
  // adjust TOC scroll to selected element/topic
  function scroll_to_element() {
    header_height = document.getElementsByTagName('header')[0].offsetHeight/2;
    toc_element_position = document.querySelector('.book-toc > li > a.active').offsetTop;
    if(document.querySelector('.book-toc > li > a.active').offsetLeft == 0) {
      toc_element_position1 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetTop;
      toc_element_position2 = document.querySelector('.book-toc > li > a.active').offsetParent.offsetHeight;
      toc_element_position = toc_element_position1 + toc_element_position2;
    }
    document.getElementsByTagName('header')[0].scrollTo(0, toc_element_position - header_height, 'smooth');
  }
  window.onload = scroll_to_element();

  // hide those labes that take up multiple lines
  l = [];
  function hide_label() {
    document
      .querySelectorAll('.book-toc > li')
      .forEach(elem => {
        window
          .getComputedStyle(elem)
          .textTransform === "uppercase"
          &&
          !elem.classList
          .contains('book-part')
          ? l.push(elem)
          : '';
      });
  }
  hide_label();
  head = document.getElementsByTagName('header')[0];
  head.addEventListener('scroll', () => {
    count = 0;
    prev_elem = '';
    l.forEach((elem) => {
      if(count === 0) {
        initial_y = elem.getBoundingClientRect().y + 20;
        count = 1;
      } else {
        if(elem.getBoundingClientRect().y < initial_y) {
          prev_elem.classList.add('hide_label');
        } else {
          prev_elem.classList.remove('hide_label');
        }
      }
      prev_elem = elem;
    });
  });
</script><div class="chapter-nav">
<div class="prev"><a href="inhibitors.html">Inhibitors</a></div>
<div class="next"><a href="thrombophilia.html">Thrombophilia</a></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2>On this page</h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#fibrinolytic">Fibrinolytic</a></li>
<li><a class="nav-link" href="#overview-of-the-fibrinolytic-system">Overview of the Fibrinolytic System</a></li>
<li><a class="nav-link" href="#disorders-of-the-fibrinolytic-system">Disorders of the Fibrinolytic System</a></li>
<li><a class="nav-link" href="#laboratory-testing-for-disorders-of-fibrinolysis">Laboratory Testing for Disorders of Fibrinolysis</a></li>
<li><a class="nav-link" href="#key-terms-82">Key Terms</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
<li><a id="book-source" href="https://github.com/brettmrice/Clinical-Microbiology/blob/blob/main/Rmd/05-09-hemostasis-fibrinolytic-system.Rmd">View source <i class="fab fa-github"></i></a></li>
          <li><a id="book-edit" href="https://github.com/brettmrice/Clinical-Microbiology/blob/edit/main/Rmd/05-09-hemostasis-fibrinolytic-system.Rmd" target="_blank">Edit this page <i class="fab fa-github"></i></a></li>
          <li><a id="buymeacoffee" href="https://buymeacoffee.com/bloodcellid" target="_blank">NEED Caffeine</a></li>
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->


</body>
</html>
